Acquiring Company
Aurora Cannabis
Acquired Company
MedReleaf Australia
Description
Aurora Cannabis Inc., a leading global medical cannabis company based in Canada, has acquired the remaining approximately 90% equity interest of MedReleaf Australia. The acquisition is valued at AUD$50 million and is expected to provide a meaningful platform for Aurora to continue growing its leading global medical cannabis position in Australia and other APAC countries.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed